Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CytomX Therapeutics Inc. (CTMX)

11.07   0.43 (4.04%) 05-24 16:00
Open: 10.69 Pre. Close: 10.64
High: 11.11 Low: 10.43
Volume: 221,730 Market Cap: 502M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.116 - 11.17 11.17 - 11.226
Low: 10.306 - 10.361 10.361 - 10.416
Close: 10.978 - 11.069 11.069 - 11.16

Technical analysis

as of: 2019-05-24 4:25:45 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 13.42     One year: 15.67
Support: Support1: 9.91    Support2: 8.94
Resistance: Resistance1: 11.49    Resistance2: 13.42
Pivot: 10.69
Moving Average: MA(5): 10.96     MA(20): 10.46
MA(100): 13.11     MA(250): 17.06
MACD: MACD(12,26): 0.11     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 67.44     %D(3): 72.61
RSI: RSI(14): 55.86
52-week: High: 27.20  Low: 8.94  Change(%): -57.8
Average Vol(K): 3-Month: 54808  10-Days: 43162

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CTMX has closed below upper band by 23.3%. Bollinger Bands are 61.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CTMX's normal range. The bands have been in this narrow range for 46 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 13 May 2019 18:09:36 Z
CytomX Therapeutics, Inc. (CTMX) Q1 2019 Earnings Call Transcript

Thu, 09 May 2019 23:58:39 Z
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates

Wed, 01 May 2019 17:16:34 Z
Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for

Wed, 20 Feb 2019 18:15:16 Z
Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for

Wed, 16 Jan 2019 16:19:00 Z
CytomX Therapeutics Shares March Higher, Can It Continue?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 45.31
Shares Float (M) 44.83
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.000
EPS Est. Current Year -1.490
EPS Est. Next Year -1.410
EPS Est. Next Quarter -0.410
Forward EPS -2.081
Book Value (p.s.) 3.920
PEG Ratio 5.51
Profit Margin
Operating Margin -105.36
Return on Assets (ttm) -21.1
Return on Equity (ttm) -99.2
Qtrly Rev. Growth 107.9
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -99.94
Levered Free Cash Flow (M) -12.58

Stock Valuations

P/E -5.53
P/E Growth Ratio 0.04
P/BV 2.82
P/S 289931616.00
P/CF -5.02

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.